Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Grignard Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103626791A details a cost-effective synthesis of 3-amino-4-fluorophenylboronic acid via Grignard borylation, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN105566367B details a palladium-free synthesis route for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN103626791B details a cost-effective Grignard route for high-purity 3-amino-4-fluorophenylboronic acid, offering supply chain stability and reduced manufacturing costs.